<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T17:11:11Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/12627" metadataPrefix="didl">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/12627</identifier><datestamp>2025-10-24T10:25:26Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
   <d:DIDLInfo>
      <dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2025-10-24T10:25:26Z</dcterms:created>
   </d:DIDLInfo>
   <d:Item id="hdl_11351_12627">
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:11351/12627</dii:Identifier>
         </d:Statement>
      </d:Descriptor>
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
               <dc:title>Mitral Transcatheter Edge-to-Edge Repair and Clinical Value of Novel Echocardiographic Biomarkers: A Hypothesis-Generating Study</dc:title>
               <dc:creator>SOLSONA CARAVACA, JAVIER</dc:creator>
               <dc:creator>Fernández Galera, Ruben</dc:creator>
               <dc:creator>Gonzalez Fernandez, Victor</dc:creator>
               <dc:creator>Airale, Lorenzo</dc:creator>
               <dc:creator>Rivas, Johny</dc:creator>
               <dc:creator>Scudeler, Luca</dc:creator>
               <dc:creator>Vallejo Camazón, Nuria</dc:creator>
               <dc:creator>Teixido-Tura, Gisela</dc:creator>
               <dc:creator>Oliveró, Ruperto</dc:creator>
               <dc:creator>Martí Aguasca, Gerard</dc:creator>
               <dc:creator>Ferreira González, Ignacio</dc:creator>
               <dc:creator>Casas, Guillem</dc:creator>
               <dc:creator>Valente, Filipa</dc:creator>
               <dc:creator>Belahnech, Yassin</dc:creator>
               <dc:creator>García del Blanco, Bruno</dc:creator>
               <dc:creator>Rodríguez Palomares, José F</dc:creator>
               <dc:creator>Galian-Gay, Laura</dc:creator>
               <dc:subject>Ecocardiografia</dc:subject>
               <dc:subject>Vàlvula mitral - Cirurgia</dc:subject>
               <dc:subject>Cor - Vàlvules - Malalties - Cirurgia</dc:subject>
               <dc:subject>Marcadors bioquímics</dc:subject>
               <dc:subject>DISEASES::Cardiovascular Diseases::Heart Diseases::Heart Valve Diseases::Mitral Valve Insufficiency</dc:subject>
               <dc:subject>Other subheadings::Other subheadings::Other subheadings::/surgery</dc:subject>
               <dc:subject>CHEMICALS AND DRUGS::Biological Factors::Biomarkers</dc:subject>
               <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Cardiac Imaging Techniques::Echocardiography</dc:subject>
               <dc:subject>ENFERMEDADES::enfermedades cardiovasculares::enfermedades cardíacas::enfermedades de las válvulas cardíacas::insuficiencia mitral</dc:subject>
               <dc:subject>Otros calificadores::Otros calificadores::Otros calificadores::/cirugía</dc:subject>
               <dc:subject>COMPUESTOS QUÍMICOS Y DROGAS::factores biológicos::biomarcadores</dc:subject>
               <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::diagnóstico por imagen::técnicas de imagen cardíaca::ecocardiografía</dc:subject>
               <dc:description>Left atrial strain; Mitral regurgitation; Ventricle–pulmonary artery coupling</dc:description>
               <dc:description>Tensió auricular esquerra; Insuficiència mitral; Acoblament ventricle-artèria pulmonar</dc:description>
               <dc:description>Tensión auricular izquierda; Insuficiencia mitral; Acoplamiento ventrículo-arteria pulmonar</dc:description>
               <dc:description>Background: Longitudinal data on reverse cardiac remodeling and outcomes after transcatheter edge-to-edge repair (TEER) are limited.&#xd;
Methods: A total of 78 patients with severe mitral regurgitation (MR) were included retrospectively. All patients had echocardiography at baseline and again six months after TEER. They were monitored for a primary composite endpoint, consisting of heart failure hospitalization and cardiovascular death, over 13 months.&#xd;
Results: Significant decreases in the left ventricular ejection fraction (LVEF), all myocardial work indices (except global wasted work), and the left atrial reservoir were observed after TEER. Additionally, there was a decrease in the pulmonary artery systolic pressure and an increase in the tricuspid annular plane systolic excursion/pulmonary artery systolic pressure (TAPSE/PASP) ratio. A post-TEER TAPSE/PASP ratio of &lt;0.47 (HR: 4.76, p-value = 0.039), and a post-TEER left atrial reservoir of &lt;9.0% (HR: 2.77, p-value = 0.047) were associated with the primary endpoint.&#xd;
Conclusions: Echocardiography post-TEER reflects impairment in ventricular performance due to preload reduction and right ventricle and pulmonary artery coupling improvement. Short-term echocardiography after TEER identifies high-risk patients who could benefit from a close clinical follow-up. The prognostic significance of LA strain and the TAPSE/PASP ratio should be validated in subsequent large-scale prospective studies.</dc:description>
               <dc:description>Belahnech, Y. is supported by a research non-conditioned grant (Rio Hortega CM22/00242).</dc:description>
               <dc:date>2025-10-24T10:25:26Z</dc:date>
               <dc:date>2025-10-24T10:25:26Z</dc:date>
               <dc:date>2025-02-19T07:14:24Z</dc:date>
               <dc:date>2025-02-19T07:14:24Z</dc:date>
               <dc:date>2024-08-01</dc:date>
               <dc:type>info:eu-repo/semantics/article</dc:type>
               <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
               <dc:identifier>http://hdl.handle.net/11351/12627</dc:identifier>
               <dc:relation>Biomedicines;12(8)</dc:relation>
               <dc:relation>https://doi.org/10.3390/biomedicines12081710</dc:relation>
               <dc:rights>Attribution 4.0 International</dc:rights>
               <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
               <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
               <dc:publisher>MDPI</dc:publisher>
               <dc:source>Scientia</dc:source>
            </oai_dc:dc>
         </d:Statement>
      </d:Descriptor>
   </d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>